Milrinone lactate
-
Milrinone lactate
structure -
-
CAS No:
100286-97-3
-
Formula:
C12H9N3O.xC3H6O3
-
Chemical Name:
Milrinone lactate
-
Synonyms:
Propanoic acid,2-hydroxy-,compd. with 1,6-dihydro-2-methyl-6-oxo[3,4′-bipyridine]-5-carbonitrile (1:?);Propanoic acid,2-hydroxy-,compd. with 1,6-dihydro-2-methyl-6-oxo[3,4′-bipyridine]-5-carbonitrile;[3,4′-Bipyridine]-5-carbonitrile,1,6-dihydro-2-methyl-6-oxo-,2-hydroxypropanoate;Milrinone lactate;Primacor;Primacor (pharmaceutical)
- Categories:
-
CAS No:
Description
Milrinone Lactate is a bipyridine agent with positive inotropic and vasodilator properties. Milrinone lactate selectively inhibits fraction III cyclic adenosine monophosphate (cAMP) phosphodiesterase isozymes in the heart and vascular muscles, thereby increasing cAMP and, consequently, an increase in cAMP-dependent intracellular ionized calcium and myocardium contractile force, and vasodilation in arteriolar and venous vascular smooth muscle. This agent improves hemodynamics in patients with ventricular dysfunction by increasing the stroke volume index and left ventricular contractility and by producing pulmonary vasodilation. (NCI04)|A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.
Characteristics
123
1.06878
White or whitish crystalline powder
448.7ºC at 760 mmHg
225.2ºC
3.04E-08mmHg at 25°C
Drug Information
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)|Compounds that specifically inhibit PHOSPHODIESTERASE 3. (See all compounds classified as Phosphodiesterase 3 Inhibitors.)|Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)|Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Corotrop
Milrinone lactate Use and Manufacturing
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:301.30
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:6
Rotatable Bond Count:2
Exact Mass:301.10625597
Monoisotopic Mass:301.10625597
Topological Polar Surface Area:123
Heavy Atom Count:22
Complexity:478
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes
Drug Function and Efficacy
Pharmacological action not specifically described
Recommended Suppliers of Milrinone lactate
-
CN
5 YRS
Business licensedTrader Supplier of Intermediates,Building blocks,API,Silicones,Peptides,Lab chemicals,Biochemicals,Pharmaceuticals,Screening Compounds,Food Additives
Learn More Other Chemicals
-
Aluminum, lactate sodium complexes, basic
68953-69-5
-
Cobalt lactate
16039-54-6
-
3-(2,4-bis(4-((5-(4,6-bis(2-aminopropylamino)-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-disulfonaphthalen-3-yl)azo)phenylamino)-1,3,5-triazin-6-ylamino)propyldiethylammonium lactate
178452-66-9
-
Lactate 2-monooxygenase Formula
9028-72-2
-
Lithium lactate Formula
867-55-0
-
2-Ethylhexyl lactate Formula
6283-86-9
-
Methyl lactate Structure
547-64-8
-
dimethyl[(3-stearoylamino)propyl]ammonium lactate Structure
55819-53-9
-
What is 4-[3-(stearoylamino)propyl]morpholinium lactate
55852-14-7
-
What is Lauryl lactate
6283-92-7